Earnings Feed
Start Free
Home/Filings/4/0000904454-26-000021
4//SEC Filing

Gut Robert 4

Accession 0000904454-26-000021

CIK 0001590560other
View on SEC.govCompany Profile

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 4:26 PM ET

Size

12.8 KB

Accession

0000904454-26-000021

Insider Transaction Report

Form 4
Period: 2026-01-12
uniQure N.V.QURE
Gut Robert
Director
Transactions
  • Exercise/Conversion

    Ordinary Shares

    [F1]
    2026-01-12$14.08/sh+17,810$250,765→ 57,955 total
  • Sale

    Ordinary Shares

    [F1][F2]
    2026-01-12$24.39/sh−17,310$422,191→ 40,645 total
  • Sale

    Ordinary Shares

    [F1][F3]
    2026-01-12$25.03/sh−500$12,515→ 40,145 total
  • Sale

    Ordinary Shares

    [F1]
    2026-01-12$25.09/sh−7,803$195,777→ 32,342 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F1][F4]
    2026-01-12−17,810→ 0 total
    Exercise: $14.08Exp: 2032-06-15→ Ordinary Shares (17,810 underlying)
Footnotes (4)
  • [F1]The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on July 8, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.02 to $25.00. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.02 to $25.04. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The Stock Option vested in full on June 15, 2023.
Signature
/s/ Christian Klemt, Attorney-in-Fact|2026-01-14

Documents

1 file

Issuer

uniQure N.V.

CIK 0001590560

→
Entity typeother

Related Parties

1
  • filerCIK 0001716268

Filing Metadata

Form type
4
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 4:26 PM ET
Size
12.8 KB
View on SEC.gov